10 months ago
IDYA
AnalystsJustin ZelinJustin Zelin's Stock Forecasts
AnalystsJustin Zelin
Sectors:
Industries:
Analyst Ranking
Top 26%
#1244 out of 4873 analysts
Average Return
+2.2%
Win Rate
24%9 out of 37
Risk vs Reward
Poor
Good
Justin Zelin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +437.68% | $3.45 | $18.55 | 2022-06-28 - 2023-06-28 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-28 - 2024-03-28 | Strong Buy |
Bellus Health IncBLU | +241.96% | $2.86 | $9.78 | 2021-07-28 - 2022-07-28 | Strong Buy |
Viking Therapeutics IncVKTX | +216.53% | $24.65 | $78.01 | 2023-05-15 - 2024-05-15 | Strong Buy |
Casi Pharmaceuticals IncCASI | +130.16% | $1.89 | $4.35 | 2022-11-15 - 2023-11-15 | Strong Buy |
Justin Zelin Analyst Color
Get additional color on Justin Zelin's coverage of popular stocks
a year ago
VKTX
a year ago
VKTX
2 years ago
IMCR
2 years ago
ETNB
2 years ago
SNDX
2 years ago
MBIO
2 years ago
LEGN
2 years ago
GRCL
2 years ago
LEGN
2 years ago
VKTX
Justin Zelin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunitybio IncIBRX | 1 | Strong Buy | $6.00 | +217.46% | Initiates Coverage On | 4 months ago |
Enliven Therapeutics IncELVN | 1 | Strong Buy | $42.00 | +129.89% | Initiates Coverage On | 5 months ago |
Ideaya Biosciences IncIDYA | 2 | Strong Buy | $62.00 | +247.73% | Maintains | 10 months ago |
Jasper Therapeutics IncJSPR | 1 | Strong Buy | $90.00 | +1,983.33% | Initiates Coverage On | 10 months ago |
Tscan Therapeutics IncTCRX | 1 | Strong Buy | $12.00 | +782.35% | Initiates Coverage On | a year ago |
Carisma Therapeutics IncCARM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | a year ago |
Viking Therapeutics IncVKTX | 4 | Strong Buy | $125.00 | N/A | Maintains | a year ago |
Verastem IncVSTM | 1 | Strong Buy | $27.00 | N/A | Assumes | a year ago |
Lyra Therapeutics IncLYRA | 1 | Strong Buy | $15.00 | N/A | Assumes | 2 years ago |
Mustang Bio IncMBIO | 4 | Strong Buy | $800.00 | N/A | Maintains | 2 years ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $91.00 | N/A | Maintains | 2 years ago |
Adicet Bio IncACET | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Prokidney CorpPROK | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
89bio IncETNB | 2 | Strong Buy | $37.00 | N/A | Maintains | 2 years ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $35.00 | N/A | Maintains | 2 years ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Gracell Biotechnologies IncGRCL | 2 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Kura Oncology IncKURA | 1 | Strong Buy | $31.00 | N/A | Initiates Coverage On | 2 years ago |
Novo Nordisk A SNVO | 1 | Strong Buy | $15.50 | N/A | Maintains | 2 years ago |
Mei Pharma IncMEIP | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Casi Pharmaceuticals IncCASI | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Bellus Health IncBLU | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 4 years ago |
Surface Oncology IncSURF | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 4 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.